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Research ethics boardAdvancements in genomic technology and genetic research have uncoverednew andunforeseen ethical and legal
issues that must now be faced by clinician–researchers. However, lack of adequate ethical training places clini-
cian–researchers in a position where they might be unable to effectively assess and resolve the issues presented
to them. The literature demonstrates that ethics education is relevant and engaging where it is targeted to the
level and context of the learners, and it includes real-world based cases approached in innovative ways. In
order to test the feasibility of a combined approach to ethics education, a conference was held in 2012 to raise
awareness and familiarize participants with the ethical and legal issues surroundingmedical technology in genet-
ics and then to have them apply this to reality-based case studies. The conference included participants from a
variety of backgrounds and was divided into three sections: (i) informative presentations by experts in the
ﬁeld; (ii) mock REB deliberations; and (iii) a second mock-REB, conducted by a panel of experts. Feedback from
participants was positive and indicated that they felt the learning objectives had been met and that the material
was presented in a clear and organized fashion. Although only an example of the combined approach in a partic-
ular setting, the success of this conference suggests that combining small group learning, practical cases, role-play
and interdisciplinary learning provides a positive experience and is an effective approach to ethics education.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Genetic research, likemany other types of studies, has its own share
of ethical and legal issues. The importance of appropriately addressing
(as well as uncovering) these issues cannot be over-emphasized. In
fact, not every case raising an ethical or legal dilemma is brought to
oversight boards for consultation nor are such committees always well
equipped to tackle them. Consider the following hypothetical scenario.icy—McGill University, 740 Dr.
ec) H3A 0G1, Canada. Tel.: +1
. This is an open access article underDr. O, a clinician–researcher in medical genetics, is conducting a
research project to identify genetic markers for cholesterol. Three
years into the project, Dr. O incidentally discovers that one of his pa-
tients, Mrs. Y, is a carrier of a gene responsible for a severe neurological
disorder that affects children and is manageable, yet not treatable. The
disease in question is a sex-linked genetic disorder that leads to a host
of symptoms including impaired vision, respiratory and digestive prob-
lems, as well as premature death. The inheritance pattern of this condi-
tion is of central importance. Females are carriers of the condition. All
the daughters of a carrier female have a 50% risk of becoming carriers
themselves —meaning that they will not display any symptoms of the
disease. A carrier's male children, however, have a 50% risk of being
affected and displaying symptoms of the disease. Although Mrs. Ythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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form did not address the issue of incidental ﬁndings. Dr. O decides to
contact Mrs. Y and reveals his results, but learns that Mrs. Y passed
away two months earlier. Dr. O knows that Mrs. Y had a younger sister
who has just gotten married, and is on the verge of starting a family of
her own.
Dr. O faces an ethical dilemma. Should he disclose his ﬁndings to
Mrs. Y's sister, or would this constitute a breach of conﬁdentiality?
Should Dr. O return this information to Mrs. Y's general practitioner?
Will the latter bewell versed tomanage such results?What is the utility
of disclosure where a genetic abnormality cannot be repaired, or the
associated disease cannot be treated?
These ethical issues are just a few of those encountered by clinician–
researchers in genetics. With advancements in genomic technology
(e.g. whole-genome and next-generation sequencing) and research,
new and unforeseen ethical obligations are crystallizing into reality.
In the 1990s, for example, ethical discourse in genetics underwent a
perceptible shift; not only in terms of particular issues, but also in the
way that ‘ethics’ itself is understood and interpreted (Knoppers and
Chadwick, 2005). For example, in the early 1990s, ethical dialog in
genetics focused primarily on issues of privacy, preventing discrimina-
tion, the basics of informed consent, and conditions of appropriate
counseling regarding testing and gene therapy; now, over twenty
years later, issues of commercialization, patenting, biobanking and
cloud computing are at the fore of ethics-based debate (Knoppers and
Chadwick, 2005; Dove et al., 2014; Huys et al., 2012). Likewise, the
emergence of new healthcare models (Bell, 1998; Epstein et al., 2010;
Kocher et al., 2010) and the increased proliferation of predictive medi-
cine and targeted therapies have led to “queries about the applicability
of existing ethical guidelines” (Knoppers and Chadwick, 2005). Ethical
behavior in twenty-ﬁrst century medical genetics should not be driven
by fears of liability, but should attempt to provide proactive and
prospective directions that protect patients and balance the rights and
duties of all the other stakeholders, including physicians, genetic
counselors and laboratory personnel (Zawati et al., 2014).
One of the problems associated with such advances in medical
genetics is that “family physicians lack the knowledge and skills to
adequately integrate genetics into their practice” (Telner et al., 2008).
This is particularly alarming knowing that, very often, a clinician–
researcher's ﬁrst point of contact for a participant's clinical followup is
normally the latter's family physician. But many studies point to the dif-
ﬁculties facing these general practitioners when dealing with genetics.
According to some authors, there is a lack of preparedness on the part
of family physicians, which “likely reﬂects the paucity of genetics
knowledge applicable to primary care that was available when [these
physicians] were in medical school” (Burke and Emery, 2002; Korf,
2002; Thurston et al., 2007; Telner et al., 2008; Houwink et al., 2011;
McElhinny et al., 2014), and also reﬂects the impressive pace at which
genetic medicine has developed and evolved. In recent years, medical
schools, clinics and hospitals have instituted policies aimed at the
education of physicians in clinical genetics. However, not only do
these policies fail to extend to the research setting (Kalichman, 2007),
but physicians are not being taught how to respond to the ethical and
legal issues that may arise in the application of genetic medicine
(Telner et al., 2008).
In view of the foregoing, clinicians and researchers must be given
the tools to identify, analyze, and resolve emerging ethical issues, and
policies must be put in place to educate these professionals as to the
ethico-legal aspects ofmedical genetics (Thomas, 2003). For this reason,
the Centre of Genomics and Policy hosted an interactive conference in
November 2012 — “Walkin' the Blurry Line Between Research and the
Clinic” (“November 2012 Conference”) — to raise awareness about the
ethical and legal implications of medical technology for clinician–
researchers. The Centre adopted a three-step approach to build aware-
ness of ethical issues: (1) informative lectures; (2) active, case-based
mock Research Ethics Board (REB) deliberations; and (3) simulatedexpert REB deliberations. It is the authors' hope that this approach will
be used as a prescriptive tool in the implementation of ethics-based
educational initiatives for medical geneticists — the better to equip
these professionals for increasingly complex ethical issues.
Although the importance of ethics education has been international-
ly and domestically recognized since the 1970s (Lehrmann et al., 2009),
there is little consensus on how best to teach ethics to medical profes-
sionals in genetics. In medical school and in clinical research and
practice, ethics education can take a backseat to the development of
clinical skills, patient care, and new technologies and protocols. More-
over, medical educational professionals are divided as to the most
effective way to teach ethics in a clinical–research environment: should
instructors use problem solving, or role-play? Practical case studies, or
small-group sessions? Should instruction be tailored to the various
stages of a medical professional's career, or should it be adapted to
particular ﬁelds of medicine?
Ethics education is further complicated when it is being taught
to clinician–researchers, due to the inherently contradictory goals of
clinical care and research. While the goal of genetic research is to
produce generalizable results and preserve “the integrity of the
research process” (Burke et al., 2014), clinicians are, in contrast,
“committed to providing care directed to the best interests of the
patient” (Burke et al., 2014). As a point of fact, the concept of therapeu-
tic misconception (i.e., the erroneous belief that research studies will
(and should) provide clinical beneﬁt to participants) is a “major
concern in bioethics” (Burke et al., 2014), to the extent that “unless
otherwise informed, research subjects will assume […] that decisions
about their care are being made solely with their beneﬁt in mind”
(Appelbaum et al., 1982). Therapeutic misconception and the divergent
goals of research and clinical care can create conﬂicting ethical obliga-
tions for clinician–researchers; this uncertainty underscores the need
for ongoing ethics education.
The objective of this paper is to inform the clinical–research ethics
community as to the successes of a comprehensive strategy to ethics
education, whereby different approaches are combined for an effective
educational experience. This “Combined Approach” focuses on the
interplay between expert instruction, case-based learning, role-play,
and small group-based active learning. First, this paper will outline
existing theories and literature on ethics education. Second, this paper
will describe the November 2012 Conference, the overall methodology
used, and the feedback received. Third, this paperwill discuss themerits
of the CombinedApproach as comparedwith other approaches to ethics
education.
2. Existing theories and literature
According to Kim et al., ethics education is characterized by rele-
vance, realism, engagement, challenge, and instruction (Kim et al.,
2006). Ethics education is “relevant” where it targets an appropriate
level of learners, matches content with instructional goals, and reﬂects
the background and diversity of learners (Kim et al., 2006). “Realism”
refers to the idea that cases approximate real-world situations: this
includes the provision of authentic materials and the presentation of
cases in an interesting and innovative way (Kim et al., 2006). Ethics
education is “engaging” where it encompasses rich and sufﬁcient
content that allows for multiple levels of analysis, the inclusion of
diverse perspectives and voices, and the opportunity for clinical
decision-making; ethics education is “challenging” where it incorpo-
rates demanding content, includes unusual, rare or multiple cases, or
employs a non-sequential methodological structure (Kim et al., 2006).
Finally, ethics education is “instructional” where educators build on
prior knowledge, provide speciﬁc feedback, and embed various teaching
aids to support student learning (Kim et al., 2006).
In reality, certain teachingmethodologies are more compatible with
these ﬁve characteristics than others. “Active learning pedagogies,”
provide intentional engagement, purposeful observation and critical
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encourage subjects to positively engage with ethical principles and
instructional materials (Tysinger et al., 1997; Bowater and Wilkinson,
2012; Brummel et al., 2010). Problem-based approaches, role-play and
practical case studies infuse ethics education with realism and hands-
on learning (Tysinger et al., 1997; Whitbeck, 1995; Sharp, 2002). The
inclusion of multiple perspectives contributes to a holistic educational
experience, (Whitbeck, 1995; Eisen and Berry, 2002; Nilstun et al.,
2001; Bowater and Wilkinson, 2012), while small group discussion is
conducive to a positive and intellectually stimulating learning environ-
ment (Tysinger et al., 1997; Bowater andWilkinson, 2012; Nilstun et al.,
2001).
Though active learning, case-based learning, role-play and small-
group learning have been recognized and approved by ethics educators,
the effectiveness of each methodology is attenuated by speciﬁc and
inherent limitations. Although small group sessions promote active
learning and engagement, it can be difﬁcult for educators to discern
whether each individual participant fully understands the ethical
nuances and obligations involved (Tysinger et al., 1997). In such cases,
participants may grasp the “bigger picture,” but are unable to apply
ethical reasoning to complex and unfamiliar scenarios. Small groups
also limit the inclusion of multiple perspectives, which creates a biased
and often incomplete view of ethical issues. For example, where respon-
sibility for ethics instruction is assumed by clinicians, a participant's
education may not incorporate a legal or community perspective; like-
wise, where small groups are comprised of participants with similar
backgrounds, cultural or religious perspectives may be omitted in the
broader discussion. Under the right circumstances, role-play is a highly
effective teaching methodology; however, it, too, becomes problematic
where participants feel awkward or resist faithful participation
(Brummel et al., 2010). If participants are uncomfortable with “acting,”
for example, their discomfortmay cloud their ability to learn and absorb
information. Similarly, case-based approaches can be narrow in scope,
and may only address one or a few important ethical issues; this deﬁ-
ciency may lead some subjects to believe that ethical issues are overly
simpliﬁed or have one authoritative solution (Brummel et al., 2010;
Tysinger et al., 1997). Last but not least, each of these methodologies
is markedly less effective where participants do not already have a
solid foundation in ethical principles and their moral/philosophical
underpinnings. For instance, participants that are unfamiliar with
Beauchamp and Childress' four principles of biomedical ethics
(i.e., autonomy, beneﬁcence, non-maleﬁcence and justice) may ﬁnd it
difﬁcult to preliminarily identify ethical issues in clinical practice
(Beauchamp and Childress, 2009).
In view of the foregoing, this paper proposes a Combined Approach
to ethics education for clinician–researchers in genetics. This Approach
seeks to remediate the disadvantages of each individual methodology
bymerging them into a uniﬁed educational strategy— thereby increas-
ing the overall efﬁcacy of ethics education through active engagement
and holistic learning.
3. The conference
The Combined Approach was ﬁrst developed at an interactive
conference — “Walkin' the Blurry Line Between Research and the
Clinic” — hosted in November 2012 by the Centre of Genomics and
Policy. As previously stated, the goal of the Conference was to raise
awareness and familiarize participants with the emerging ethical and
legal implications surrounding medical technology for clinician–
researchers in genetics; and then to have them apply this knowledge
to a practical case study. Participants included research assistants,
graduate students, study managers and/or coordinators, investigators,
physicians, residents, REB members and nurses. Some of the partici-
pants had prior research ethics education, others did not.
The Conference was divided into three distinct sessions:
(i) informative presentations by experts in the ﬁeld (“Session 1”);(ii) mock REB deliberations (“Session 2”); and (iii) a second mock
REB, conducted by a panel of experts (“Session 3”).
Session 1 comprised three informative presentations from a
clinician–researcher in medical genetics and genomics; a professor in
medical genetics; and a lawyer and expert inmedical liability and ethics.
These lectures focused primarily on rare disease consortia, genome
analysis for neonates, and the gap between research and clinical care.
Session 2 consisted of mock REB deliberations. Each participant was
given a case-based scenario that was designed to reﬂect topical and
practical ethical issues in medical genetics. As a point of fact, the case
of Dr. O and Mrs. Y (as described at the outset of this article) was the
very same factual scenario thatwas used during Session 2 of this Confer-
ence. Once participants had been provided with the ﬁctional case of
Dr. O and Mrs. Y, they were divided into small groups and instructed
to deliberate among themselves as mock REBs. These small groups
were speciﬁcally constituted to reﬂect real-world ethics committees.
Accordingly, participants were divided by academic and professional
background, such that (where possible) each group contained a lawyer,
an ethicist, a researcher, a community member and a physician. Group
discussion was facilitated by an expert (“the facilitator”), who guided
debate around ethics-based questions. Facilitators were chosen from
among Conference organizers and speakers (each of whom had been
trained in genetics research, policy or clinical care); while some facilita-
tors were encouraged to adopt neutral positions, others contributed
their unique (and informed) perspectives to the general discussion. Ul-
timately, the role of the facilitator was to bring out and clarify the
thoughts of the participants, and to summarize the conclusions of
eachmock REB. The facilitator was providedwith a list of suggested dis-
cussion points and informational bullets prior to the start of Session 2.
At the outset of this Session, participants were given time to read the
case study in their small groups. Ten minutes was spent discussing
ethically-based questions; another 15 to 20 min was then spent
summarizing the discussion and coming up with next steps and/or
outstanding issues.
Session 3 consisted of a second mock REB, conducted by a panel of
REB experts. Conference participants were instructed to observe this
REB and compare its deliberations with those that they themselves
had conducted during Session 2. The expert panel was composed of
REB experts in genetics, including: two scientists versed in genetics,
an ethicist, a jurist and two community members. This expert panel
was expressly constituted to reﬂect the constitution of a real-world
REB. Each member of Session 3's mock REB had previously served as a
facilitator in Session 2. As a result, panelists were able to pinpoint
those areas and questions that had been of particular interest to
participants, and to adapt their deliberations accordingly. First, the
pre-appointed Chair of the REB made his introductions and presented
the fact scenario, outlining questions and issues to be discussed. Second,
the REB members brainstormed questions and ethical issues; a mock-
principal investigator was also on hand for a question and answer
period, which was based on participant questions from Session 2.
Once the investigator had ﬁnished, the REB panel summarized their
discussion and formulated a response to Dr. O's letter. Although the
REB's response provided a clear path forward, it stopped short of
being deﬁnitive — the better to reﬂect the complexity of ethical issues,
and to avoid oversimpliﬁcation or the assumption of authoritative
solutions (Brummel et al., 2010; Tysinger et al., 1997).
3.1. Feedback from the conference
The feedback from the Conference participants was very positive. Of
an approximate total of seventy-ﬁve participants, forty-eight responded
to a comprehensive satisfaction survey about their experience. On aver-
age, all forty-eight either “strongly agreed” or “agreed” that: (1) the
Conference met its outlined learning objectives; (2) the informational
content was appropriate to participants; (3) the material was well-
organized; (4) the presenters displayed good subject knowledge,
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use of visual aids; and (5) the presenters provided adequate opportuni-
ty for questions and discussion, and encouraged attendees to ask
questions. Of the twenty-four participants who contributed to the
“Comments” section of the survey, four participants speciﬁcally
mentioned that the case study was the most valuable component of
the Conference, while seven participants expressed their approval of
the mock REB and case study. It is important to note, however, that
feedback from the Conference participants (and the conclusions
drawn therefrom) is subject to limitations. Only sixty-four percent of
participants responded to the comprehensive survey, and feedback
was entirely voluntary in nature. Moreover, the conﬁdence and/or
competence of participants to address similar questions in the future
were not assessed.
3.2. Success and challenges of the conference
The success of the November 2012 Conference can be attributed, in
large, to its Combined Approach to ethics education, which sought to
foster analytical and critical thinking in clinician–researchers by fusing
small group learning, practical cases, role-play and interdisciplinary
learning.
Session 1 provided participants with an informational basis upon
which to build their ethical analyses. As previously discussed, one of
themain issueswith ethics education today is that clinician–researchers
do not have a grounding in ethics or moral philosophy. Methodologies
that focus solely on cases or role-play fail to account for such founda-
tional deﬁciencies, and thus make for an incomplete education. The in-
corporation of large-scale lectures into Session 1 of this Conference
allowed participants to contextualize a variety of ethical principles.
This contextualization led to a more nuanced appreciation of the practi-
cal scenarios and REB deliberations of Sessions 2 and 3. An information-
based component of ethics education can be adapted to suit the needs
and interests of various audiences — in this case, clinician–researchers
in medical genetics. The informational nature of Session 1 thus set the
instructional tone for the remainder of the Conference, and laid the
foundation for active discussion.
Session 2 used role-play, small groups and practical cases to encour-
age critical thinking among clinician–researchers. This combination of
approaches minimized the disadvantages inherent in each distinct
methodology. Whereas role-play, for example, has the tendency to
cause social discomfort among participants (Brummel et al., 2010), the
addition of small groups created an environment that favored active
learning and open participation. By using practical, case-based studies,
participants are likewise encouraged to place themselves in the minds
of REB representatives, and to think about ethics in the context of
real-world scenarios (Tysinger et al., 1997). Thus, the Combined Ap-
proach not only imagines realistic and intellectually-challenging ethical
problems, but also allows for the improvement of critical thinking skills
through active learning and engagement. Instead of merely providing
participants with information, the Conference sought to foster the
type of critical thinking and issue analysis that is necessary for an ethical
medical practice.
In Session 3, the participants were able to compare and contrast
their own experiences with a simulated professional REB. In so doing,
the participants were able to validate their personal ethical experiences
through observation, and determine whether they succeeded or erred
in their ethical analyses. Through critical thinking and reﬂection, the
participants improved their own ethical skills and also gleaned impor-
tant insight into the functioning of a real REB. The presence of ethicists,
doctors, jurists and community members provided participants with a
well-rounded ethical perspective — an element that is often lacking
where ethics education is the byproduct of a singular methodological
exercise. The inclusion of multiple perspectives also provides partici-
pants with viewpoints that are aligned with their own, in consonance
with their educational backgrounds,moral upbringing, and professionalafﬁliations. Moreover, graduate students were able to see ﬁrsthand the
dilemmas that their supervisors face. This relational aspect enables
participants to contextualize ethical problems and imagine their
own reactions to similar scenarios. The repetition of a mock REB in Ses-
sion 3 also helped mitigate any discomfort felt by participants during
Session 2, and helped alleviate concerns over the narrow scope of
case-based approaches (Brummel et al., 2010; Tysinger et al., 1997).
Notwithstanding the above, it is important to keep in mind that the
participant views of Session 3may have been biased (given the number
of Conference participants and their professional afﬁliations and experi-
ences), and that any ﬁndings reported herein are not automatically
generalizable.
The Combined Approach is not without its disadvantages, however.
A conference that brings together a sufﬁcient number of experts and
facilitators of varyingprofessional backgrounds can be anorganizational
quagmire. Training sessions and/or debrieﬁngs may also be required to
ensure that these experts are aware of the objectives of the conference
and the limitations of the case study itself. The formulation of topical
case studies and informative presentations requires a signiﬁcant com-
mitment involving time, effort and resources. Clinician–researchers
themselves must be willing to partake as conference attendees, which
may prove problematic if such conferences are optional and if partici-
pants must miss work in order to attend. Finally, there is still the possi-
bility that the problems inherent to each singular methodology will
appear in the context of the Combined Approach (depending on the
circumstances). As such, it is important to note that this research pro-
vides an example of the Combined Approach, however further research
and validation are still needed in various settings. Our goal was simply
to demonstrate the overall positive experience and feedback of using
the Combined Approach for ethics education.
4. Conclusions
Clinician–researchers in medical genetics, including the well-
meaning but unprepared Dr. O, must be able to identify and analyze
ethical issues in their professional practices (Eisen and Berry, 2002).
Outside the conﬁnes of a classroom and pre-set curricula, ethics educa-
tion for clinician–researchers can be difﬁcult to implement in an effec-
tive and sustainable way (Brummel et al., 2010; Thomas, 2003;
Tysinger et al., 1997). As demonstrated, workshop-based learning is
better suited to clinician–researchers, who may be far removed from
classroom environments and have become accustomed to practical,
case-based learning. Accordingly, the Combined Approach seeks to
improve ethics education by amalgamating several methodologies
into one uniﬁed strategy.
Notwithstanding the problems associated with the Combined Ap-
proach (such as time/resource constraints, willingness of participants
to attend, and the need for facilitators and experts), this methodology
allows for the development of ethical skills by fostering a ﬂexible, infor-
mative, and realistic approach to ethics education. By combining the
most effective teaching methodologies into one combined approach,
theﬁve core attributes of ethics instruction (relevance; realism; engage-
ment; challenge; instruction) as discussed at the outset of this paper are
substantially fulﬁlled (Kim et al., 2006). The use of small groups, experts
and facilitators increases participant comfort, while the informational
component is tailored to the various stages of professional careers as
well as to particular ﬁelds of interest (Sharp, 2002).
We recommend that the Combined Approach described in this
paper be used prescriptively, and be adopted bymedical schools, clinics
and hospitals to continually update physicians as to the ethical and legal
obligations associated with medical genetics. Given the recent prolifer-
ation of genetic testing, research and personalized medicine, local phy-
sician associations should abide by the World Medical Association's
Ethics Manual (2009) and initiate “workshops […] for their members
to help guide them to adapt and cope with what is now recognized as
the future of their practice: personalized medicine” (Zawati et al.,
20 M. Zawati et al. / Applied & Translational Genomics 4 (2015) 16–202011). Such policy initiatives will ensure that human genetics is not
only at the forefront of medical science, but is also ethically andmorally
just. As a result, clinician–researchers such as Dr. O will be able to adapt
their practices to a wide variety of ethical scenarios.
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